12 | Peptides (Polypeptides)IBA
06/2021
-
11/2002 |
7 | Radioisotopes (Radionuclides)IBA
01/2019
-
08/2003 |
6 | AntigensIBA
02/2015
-
08/2003 |
5 | 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
01/2023
-
11/2002 |
5 | Proteins (Proteins, Gene)FDA Link
01/2023
-
02/2004 |
3 | arginyl-glycyl-aspartic acidIBA
02/2007
-
11/2002 |
3 | Integrin beta3 (GPIIIa)IBA
02/2007
-
11/2002 |
2 | Exenatide (Byetta)FDA Link
01/2023
-
01/2023 |
2 | Caspase 3 (Caspase-3)IBA
01/2023
-
11/2020 |
2 | Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2023
-
01/2020 |
2 | Glucagon-Like Peptide-1 ReceptorIBA
01/2023
-
11/2020 |
2 | Pentetic Acid (DTPA)FDA LinkGeneric
01/2019
-
10/2005 |
2 | HaptensIBA
02/2015
-
10/2012 |
2 | Bispecific AntibodiesIBA
02/2015
-
10/2005 |
2 | IntegrinsIBA
02/2014
-
08/2004 |
2 | Monoclonal AntibodiesIBA
10/2011
-
02/2004 |
2 | Peptide Receptors (Peptide Receptor)IBA
02/2007
-
08/2004 |
2 | cyclic arginine-glycine-aspartic acid peptideIBA
02/2007
-
11/2006 |
2 | aspartic acid glycine arginineIBA
11/2006
-
08/2004 |
2 | Interleukin-8 (Interleukin 8)IBA
12/2004
-
07/2004 |
2 | Integrin alphaVbeta3IBA
08/2004
-
11/2002 |
1 | Carbonic Anhydrase IXIBA
01/2023 |
1 | AntibodiesIBA
01/2023 |
1 | Deoxyglucose (2 Deoxy D glucose)IBA
01/2023 |
1 | sodium-iodide symporter (sodium iodide symporter)IBA
01/2023 |
1 | Glucose (Dextrose)FDA LinkGeneric
01/2023 |
1 | 1,4,7- triazacyclononane- N,N',N''- triacetic acid (NOTA)IBA
01/2023 |
1 | penetratinIBA
06/2021 |
1 | nonaarginineIBA
06/2021 |
1 | Epidermal Growth Factor (EGF)IBA
06/2021 |
1 | Biomarkers (Surrogate Marker)IBA
01/2020 |
1 | 1-phenyl-3,3-dimethyltriazene (PDT)IBA
01/2019 |
1 | Photosensitizing Agents (Photosensitizers)IBA
01/2019 |
1 | Insulin (Novolin)FDA Link
01/2016 |
1 | DOTA- tyrosyl- lysyl(histaminyl- succinyl- glycyl)- glutamyl- lysyl(histaminyl- succinyl- glycyl)amideIBA
02/2015 |
1 | Glucagon-Like Peptide 1 (GLP 1)IBA
05/2014 |
1 | Indium-111IBA
05/2014 |
1 | procaine isothiocyanate (PRIT)IBA
09/2013 |
1 | PhosphatidylserinesIBA
01/2011 |
1 | Thioacetamide (Thioacetamid)IBA
02/2007 |
1 | PeptidomimeticsIBA
11/2006 |
1 | Extracellular Matrix ProteinsIBA
11/2006 |
1 | VitronectinIBA
11/2006 |
1 | PeptoidsIBA
11/2006 |
1 | Amino AcidsFDA Link
10/2005 |
1 | Carcinoembryonic AntigenIBA
10/2005 |
1 | IndiumIBA
10/2005 |
1 | AcidsIBA
10/2005 |
1 | tyrosyl-lysineIBA
10/2005 |
1 | N-acetylphenylalanyllysineIBA
10/2005 |
1 | Citric Acid (Citrate)FDA LinkGeneric
12/2004 |
1 | RadiopharmaceuticalsIBA
12/2004 |
1 | CXC ChemokinesIBA
07/2004 |
1 | Protein Isoforms (Isoforms)IBA
07/2004 |
1 | Chelating AgentsIBA
07/2004 |
1 | connective tissue-activating peptide (CTAP-III)IBA
07/2004 |
1 | G250 monoclonal antibodyIBA
02/2004 |
1 | 1- (4- isothiocyanatobenzyl)diethylenetriaminepentaacetic acidIBA
02/2004 |
1 | Immunoconjugates (Immunoconjugate)IBA
02/2004 |
1 | Interleukin-2 (IL2)IBA
08/2003 |
1 | InterferonsIBA
08/2003 |
1 | Cyclophosphamide (Cytoxan)FDA LinkGeneric
08/2003 |